Bluestar BioAdvisors presents
Biotech Matters Podcast
The Bluestar BioAdvisors Team and expert guests translate the data of today into implications for the business of science of tomorrow.
Subscribe + listen:
Bluestar BioAdvisors presents
The Bluestar BioAdvisors Team and expert guests translate the data of today into implications for the business of science of tomorrow.
Subscribe + listen:
The Bluestar BioAdvisors team shares insights on drug pipelines and predicts industry trends. Each episode is hosted by a senior member of our New York City based life sciences consulting firm. The host is typically joined by an external expert guest, with whom the host expands on their experiences providing insights and recommendations for industry leaders and emergent innovators.
Ep. 8: March 27, 2026
Bluestar Principal Jeff Fineberg is joined by pediatric nephrologist and researcher Dr. Howard Trachtman. The two talk about several developments in FSGS, including: sparsentan’s data from the DUET and DUPLEX trials; the use of surrogate endpoints in FSGS for FDA approval; the challenges facing treatment durability, and the possibility of biomarkers for personalized therapy; and insights from a recent clinical trial of a TRPC6 inhibitor in FSGS.
Ep. 7: Nov. 3, 2025
In this episode, Dr. Pietro Canetta revisits key updates in IgA nephropathy and FSGS, including recent drug developments, trial outcomes, and expectations for ASN Kidney Week 2025.
Ep. 6: Dec. 9, 2024
Principal Jeff Fineberg, PhD, sits down with Vlado Perkovic, MBBS, PhD, to discuss the IgA nephropathy trial data presented at Kidney Week 2024.
Ep. 5: Oct. 21, 2024
Principal Jeff Fineberg, PhD, welcomes back returning guest nephrologist Beatrice Goilav, MD, to discuss the program featured at Kidney Week 2024 in San Diego.
Ep. 4: July 24, 2024
Bluestar's Principal Jeff Fineberg and Managing Director Erin Olsen discuss antibody-drug conjugate (ADC) therapies following the ASCO conference.
Ep. 3: May 30, 2024
Bluestar's Principal Jeff Fineberg and Managing Director Erin Olsen discuss interesting abstracts related to two topics in particular: unmet needs in 1L therapy and the KRAS G12C mutation landscape.
Ep. 2: Dec. 6, 2023
After attending ASN Kidney Week, Bluestar Principal Jeff Fineberg sits down with Dr. Pietro Canetta to talk all things IgA nephropathy (IgAN).
Ep. 1: Nov. 1, 2023
Principal Jeff Fineberg, PhD, sits down with nephrologist Beatrice Goilav, MD, to talk all things Kidney Week. Dr. Goilav offers her thoughts on an ideal day-by-day itinerary, as well as her hopes for what will be presented at a variety of sessions.